Back to DAVENPORT & Co LLC DAVENPORT & Co LLC

CGTXCGTX
5 quarters

Position history for DAVENPORT & Co LLCDAVENPORT & Co LLC's holdings in COGNITION THERAPEUTICS INC

Yes. Davenport holds 4,248,410 shares of CGTX (Cognition Therapeutics), worth $4.1M, as of its Q3 2026 13F filing. It reduced the position by 11,101 shares (-0.3%) from Q2 2026. Davenport has held CGTX since Q3 2025, across 5 quarterly 13F filings.

Current Value

$4.1M

Current Shares

4.2M

Total Value Change

+$447,870

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
4.2M
-0.3%
$4.1M0.0%$0.96
0
2026-Q2
Increased
4.3M
+47.2%
$4.9M0.0%$1.15
37
2026-Q1
Increased
2.9M
+0.7%
$2.2M0.0%$1.02
26
2025-Q4
Increased
2.9M
+6.8%
$3.9M0.0%$1.37
29
2025-Q3
New
2.7M
-
$3.6M0.0%$1.43
37

Other major holders of CGTX: VANGUARD GROUP INC, Pathstone Holdings, LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used